MSTN and sarcopenia: Another open question is the role of biomarkers of biological aging and musculoskeletal reserve, including proteomic risk scores, low IGF-1, serum myostatin, TNF-α, and vitamin D, which may help identify individuals at risk for sarcopenia and poor recovery [111,112,113].